Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure - FERRIC-HF


The goal of this trial was to evaluate the effect of intravenous (IV) iron in addition to optimal conventional therapy on exercise and functional capacity in patients with New York Heart Association (NYHA) class II or III chronic heart failure and iron deficiency.